Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bristol-Myers Squibb profiles novel MCH1 receptor antagonist

Sep. 3, 2012

Mechanism of action of epelsiban besilate further elucidated

Sep. 3, 2012

CB2 receptor agonist proves useful for the treatment of erectile dysfunction

Sep. 3, 2012

Takeda presents novel inhibitors of ACC2

Sep. 3, 2012

Topical cream improves female sexual arousal disorder in phase III trial

Aug. 31, 2012

Noven files NDA for therapy for menopausal vasomotor symptoms

Aug. 30, 2012

FDA provides recommendations for Proellex trial

Aug. 28, 2012

Tenelia set for launch in Japan

Aug. 28, 2012

Recruitment begins for phase III trial in children with precocious puberty

Aug. 28, 2012

Growject approved for fourth indication in Japan

Aug. 24, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...